HOME

TheInfoList



OR:

SRT-2104 is an experimental drug that was studied by Sirtris Pharmaceuticals as a
small-molecule Within the fields of molecular biology and pharmacology, a small molecule or micromolecule is a low molecular weight (≤ 1000 daltons) organic compound that may regulate a biological process, with a size on the order of 1 nm. Many drugs ar ...
activator of the sirtuin subtype SIRT1. The compound progressed to Phase II human trials for
Type II diabetes Type 2 diabetes, formerly known as adult-onset diabetes, is a form of diabetes mellitus that is characterized by high blood sugar, insulin resistance, and relative lack of insulin. Common symptoms include increased thirst, frequent urination, ...
before development was discontinued, however it continues to be widely used in animal research into the functions of SIRT1.


See also

* SRT-1460 * SRT-1720 * SRT-2183 *
SRT-3025 SRT-3025 is an experimental drug that was studied by Sirtris Pharmaceuticals as a small-molecule activator of the sirtuin subtype SIRT1. It has been investigated as a potential treatment for osteoporosis, and anemia. See also * SRT-1460 * SRT ...
* STAC-9


References

Anti-aging substances 4-Morpholinyl compunds Thiazoles 3-Pyridyl compounds Amides {{pharm-stub